EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Screening and Preliminary Validation of Parthanatos-Related Key Genes in Asthma Using Transcriptomic and Machine Learning Approaches

Jiawei Zhao iD, Danni Li iD, Chunli Yang iD, Chunyan Liu, Xiaolin Ma iD

Journal of Inflammation Research · 2026-01 · Volume 19 · 1-20

DOI: 10.2147/jir.s557154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-01. Verfasst von Jiawei Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Fifth Affiliated Hospital of Dali University (Baoshan People's hospital), Baoshan, People's Republic of China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Parthanatos, a Poly polymerase 1 mediated programmed cell death pathway, remains poorly characterized in asthma pathogenesis. This study integrated transcriptomic data from public asthma datasets and parthanatos-related genes (PRGs) to identify the key molecular players. Patients and Methods: Asthma-related datasets GSE69683 (411 asthma and 87 control samples) and GSE134544 (10 asthma and 21 control samples) were obtained from public databases. Through differential expression analysis, weighted gene co-expression network analysis (WGCNA), and machine learning, three genes (ANXA3, CEACAM6, and 8d) were prioritized. Functional enrichment linked these genes to inflammatory and metabolic pathways, including complement/coagulation cascades, spliceosomes, and citrate cycle.

Results

Immune infiltration analysis revealed significant disparities in naive B cells, eosinophils, neutrophils, resting mast cells, and CD8 + T cells between asthmatic and control groups. These genes are correlated with lung injury, neoplasms, and broader respiratory diseases, highlighting their clinical relevance. Predictive analysis identified environmental compounds (eg benzo(a)pyrene, and estradiol) interacting with all three genes, suggesting therapeutic targets. Preliminary experimental validation via RT-qPCR suggested the upregulation of CEACAM6 and CRISP3 expression in asthmatic blood samples.

Conclusion

In conclusion, we identified and preliminarily validated ANXA3, CEACAM6, and CRISP3 as parthanatos-related key genes in asthma, providing a foundational gene signature for subsequent research into asthma diagnostics and mechanisms.

Schlagwörter

Stichwörter der Autor:innen

asthmaenrichment analysisimmune infiltrationkey genesparthanatos

Autor:innen und Institutionen

  • Department of Pediatrics, The Fifth Affiliated Hospital of Dali University (Baoshan People's hospital), Baoshan, People's Republic of China.
  • Department of Neonatology, The Fifth Affiliated Hospital of Dali University (Baoshan People's hospital), Baoshan, People's Republic of China.
  • Department of Gynecology, The Fifth Affiliated Hospital of Dali University (Baoshan People's Hospital), Baoshan, People's Republic of China.

ORCID-Profile: Jiawei Zhao, Danni Li, Chunli Yang, Xiaolin Ma

Zitieren

APA

Zhao, J., Li, D., Yang, C., Liu, C., & Ma, X. (2026). Screening and Preliminary Validation of Parthanatos-Related Key Genes in Asthma Using Transcriptomic and Machine Learning Approaches. Journal of Inflammation Research, Volume 19, 1-20. https://doi.org/10.2147/jir.s557154

Vancouver

Zhao J, Li D, Yang C, Liu C, Ma X. Screening and Preliminary Validation of Parthanatos-Related Key Genes in Asthma Using Transcriptomic and Machine Learning Approaches. Journal of Inflammation Research. 2026;Volume 19:1-20. doi:10.2147/jir.s557154

BibTeX
@article{Zhao2026,
  author = {Zhao, Jiawei and Li, Danni and Yang, Chunli and Liu, Chunyan and Ma, Xiaolin},
  title = {Screening and Preliminary Validation of Parthanatos-Related Key Genes in Asthma Using Transcriptomic and Machine Learning Approaches},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--20},
  doi = {10.2147/jir.s557154}
}
Kostenlos starten →